Literature DB >> 24876553

Confusion Regarding Duration of Insulin Action: A Potential Source for Major Insulin Dose Errors by Bolus Calculators.

John Walsh1, Ruth Roberts2, Lutz Heinemann3.   

Abstract

People with diabetes on insulin pumps often use a bolus calculator (BC) to obtain insulin dose recommendations. After the first bolus of the day, residual insulin activity, called bolus insulin on board (BOB), must be correctly accounted for to reduce the size of subsequent boluses and minimize the insulin stacking that would otherwise occur. Critical to achieving this calculation is having an appropriate duration of insulin action (DIA) setting in the BC. Unfortunately, the widespread use of inappropriately short DIAs may be causing unrecognized "stacking" of insulin that leads to unexplained hypoglycemic events. Currently, there is no widely accepted definition or value of the DIA for use in a BC. Various shortcomings regarding the selection of an appropriate DIA setting have led to considerable confusion among clinicians and insulin pump users about this important concept. Traditional pharmacological studies used to determine the pharmacodynamic (PD) properties of rapid-acting insulins create a misleading impression that insulin action times (IATs) in daily life vary from 3 to 5 hours and cause IATs to appear more variable than they actually are. These IAT time ranges are not appropriate for use as the DIA time value required to obtain an accurate bolus recommendation from a BC. We highlight the problems that arise when an inappropriately short DIA leads to excessive bolus recommendations, provide a research protocol to accurately measure DIA, and suggest appropriate DIA time recommendations for use in current clinical practice.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  duration of insulin action; insulin action time; insulin pumps; insulin therapy; pharmacodynamics; pharmacokinetics; rapid acting insulin analogs

Year:  2014        PMID: 24876553      PMCID: PMC4454113          DOI: 10.1177/1932296813514319

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  22 in total

Review 1.  Measurement of insulin absorption and insulin action.

Authors:  Lutz Heinemann; James H Anderson
Journal:  Diabetes Technol Ther       Date:  2004-10       Impact factor: 6.118

2.  Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.

Authors:  Reinhard H A Becker; Annke D Frick; Leszek Nosek; Lutz Heinemann; Klaus Rave
Journal:  Diabetes Care       Date:  2007-08-03       Impact factor: 19.112

3.  Poor adherence to integral daily tasks limits the efficacy of CSII in youth.

Authors:  M A O'Connell; S Donath; F J Cameron
Journal:  Pediatr Diabetes       Date:  2011-04-06       Impact factor: 4.866

4.  Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

Authors:  H Hanaire-Broutin; V Melki; S Bessières-Lacombe; J P Tauber
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

5.  Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes.

Authors:  H B Mortensen; A Lindholm; B S Olsen; B Hylleberg
Journal:  Eur J Pediatr       Date:  2000-07       Impact factor: 3.183

Review 6.  Variability of insulin absorption and insulin action.

Authors:  Lutz Heinemann
Journal:  Diabetes Technol Ther       Date:  2002       Impact factor: 6.118

7.  Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

Authors:  S R Mudaliar; F A Lindberg; M Joyce; P Beerdsen; P Strange; A Lin; R R Henry
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

Review 8.  Bolus calculator: a review of four "smart" insulin pumps.

Authors:  Howard Zisser; Lauren Robinson; Wendy Bevier; Eyal Dassau; Christian Ellingsen; Francis J Doyle; Lois Jovanovic
Journal:  Diabetes Technol Ther       Date:  2008-12       Impact factor: 6.118

9.  Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.

Authors:  L Heinemann; C Weyer; M Rauhaus; S Heinrichs; T Heise
Journal:  Diabetes Care       Date:  1998-11       Impact factor: 19.112

Review 10.  Ultrafast-acting insulins: state of the art.

Authors:  Lutz Heinemann; Douglas B Muchmore
Journal:  J Diabetes Sci Technol       Date:  2012-07-01
View more
  21 in total

1.  Bolus Estimation--Rethinking the Effect of Meal Fat Content.

Authors:  Srinivas Laxminarayan; Jaques Reifman; Stephanie S Edwards; Howard Wolpert; Garry M Steil
Journal:  Diabetes Technol Ther       Date:  2015-08-13       Impact factor: 6.118

Review 2.  Boluses in Insulin Therapy.

Authors:  Ralph Ziegler; Guido Freckmann; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2016-07-10

Review 3.  Physical activity and type 1 diabetes: time for a rewire?

Authors:  Sheri R Colberg; Remmert Laan; Eyal Dassau; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2015-01-06

Review 4.  Bolus Advisors: Sources of Error, Targets for Improvement.

Authors:  John Walsh; Ruth Roberts; Timothy S Bailey; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2017-07-25

Review 5.  Bolus calculators.

Authors:  Signe Schmidt; Kirsten Nørgaard
Journal:  J Diabetes Sci Technol       Date:  2014-05-19

6.  Bolus Calculator Settings in Well-Controlled Prepubertal Children Using Insulin Pumps Are Characterized by Low Insulin to Carbohydrate Ratios and Short Duration of Insulin Action Time.

Authors:  Ragnar Hanas; Peter Adolfsson
Journal:  J Diabetes Sci Technol       Date:  2016-07-29

Review 7.  [New technologies in diabetology. How far are we from a closed loop?].

Authors:  G Freckmann
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

8.  Issues and Ideas in Bolus Advisor Research With Commentary on "A Methodology to Compare Insulin Dosing Algorithms in Real-Life Settings".

Authors:  John Walsh
Journal:  J Diabetes Sci Technol       Date:  2017-07-06

9.  Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control.

Authors:  Itamar Raz; Gabriel Bitton; Dmitry Feldman; Tal Alon; Andreas Pfutzner; William V Tamborlane
Journal:  J Diabetes Sci Technol       Date:  2015-04-16

10.  Unknown Safety and Efficacy of Smartphone Bolus Calculator Apps Puts Patients at Risk for Severe Adverse Outcomes.

Authors:  Irl B Hirsch; Christopher G Parkin
Journal:  J Diabetes Sci Technol       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.